Pulmonx (LUNG) Other Non-Current Liabilities (2020 - 2022)

Pulmonx's (LUNG) quarterly Other Non-Current Liabilities came in at $179000.0 in Q2 2022, little changed on a QoQ basis from $179000.0 in Q1 2022.

Pulmonx (LUNG) Other Non-Current Liabilities (2020 - 2022) Analysis & Trends

Pulmonx (LUNG) has 3 years of Other Non-Current Liabilities data on file, last reported at $179000.0 in Q2 2022.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $179000.0 in Q2 2022; TTM through Jun 2022 was $179000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $179000.0, changed N/A from the prior year.
  • Other Non-Current Liabilities for Q2 2022 stood at $179000.0, roughly flat from $179000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for LUNG reached as high as $1.9 million in Q3 2020 and fell as low as $179000.0 in Q4 2021.
  • Historically, Other Non-Current Liabilities has averaged $598250.0 across 3 years, with a median of $179000.0 in 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Pulmonx 49.94 Mn -19.81 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 179,000.00
Mar 31, 2022 179,000.00
Dec 31, 2021 179,000.00
Sep 30, 2020 1.86 Mn